Bevacizumab or fibronectin gene editing inhibits the osteoclastogenic effects of fibroblasts derived from human radicular cysts

Bevacizumab or fibronectin gene editing inhibits the osteoclastogenic effects of fibroblasts derived from human radicular cystsBevacizumab or fibronectin gene editing inhibits the osteoclastogenic effects of fibroblasts derived from human radicular cysts, Published online: 31 October 2018; doi:10.1038/s41401-018-0172-xBevacizumab or fibronectin gene editing inhibits the osteoclastogenic effects of fibroblasts derived from human radicular cysts

Source: Acta Pharmacologica Sinica - October 31, 2018 Category: Drugs & Pharmacology Authors: Hai-Cheng Wang Peng Wang Yuan-wei Chen Yan Zhang Source Type: research